Rhythm Pharmaceuticals, Inc. · Brief

Next report

3 days

Nov 3 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 8≥ implied

Feb 26 '25±13.2%▲+4.49%×0.34

May 7 '25±7.3%▲+3.06%×0.42

Aug 5 '25±8.3%▼−1.85%×0.22

Nov 4 '25±9.9%▼−7.69%×0.77

Jan 9 '26±5.6%▲+3.65%×0.66

Q1 FY26±13.6%▼−1.09%×0.08

May 5 '26±10.7%▲+7.86%×0.73

Q2 FY26±11.3%▲+2.92%×0.26

quarterimplied−15%0+15%realized×

Q2 FY26±11.3%▲+2.92%×0.26

May '26±10.7%▲+7.86%×0.73

Q1 FY26±13.6%▼−1.09%×0.08

Jan '26±5.6%▲+3.65%×0.66

Nov '25±9.9%▼−7.69%×0.77

Aug '25±8.3%▼−1.85%×0.22

2 older reports

May '25±7.3%▲+3.06%×0.42

Feb '25±13.2%▲+4.49%×0.34

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 3 report · est.

Bull2 of 4

10disclosed supplier and customer ties in SEC filingsSEC filings

305managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

6 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

31managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

RYTM report session

No linked exposure.

Oct 21impliedImplied move: ±8.9% into Nov 3 earnings (Oct 21 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.